Breast Cancer: Separating Fact from Fiction

Breast Cancer is probably the most talked-about form of cancer today. Millions upon millions of dollars are donated from regular people just like you into research that will help patients overcome breast cancer, and treatments that save lives all over the country. In spite of all the money spent on Breast Cancer Awareness, a lot of people are still woefully ill-informed about the truths of Breast Cancer, and their knowledge regarding breast cancer is largely the result of hearsay and hypotheses put forth in the past that have now become outdated. Let’s talk about some of these myths now, and separate the fact from the fiction.

Fiction: Breast Cancer is Primarily Hereditary, and women are only at high risk if they have a family history of breast cancer.

Many people believe that breast cancer is for the most part a genetic condition, and that risk is carried down from parents to daughters. In reality, it is believed that only between five and ten percent of breast cancer cases are the result of genetic mutations acquired from the mother or father.

Of course, having one of these mutations can significantly increase your risk of breast cancer. For example, women that have particular BRCA mutations are eighty percent likely to experience breast cancer at some point in their lives.

Just because you have a family history doesn’t mean that you are definitely going to get cancer, however. Having a daughter, sister, or mother with breast cancer, for example, doubles cancer risk. If you have two close family members with the condition, your risk increases by three times compared to average.

Out of all breast cancer cases, only around twenty to thirty percent have immediate relatives that have experienced the condition in their lives. This means that the majority of women do not experience breast cancer as a result of direct hereditary risk passed down from their relatives.

Truth: Although genetic heritage does play a role, it is not the only factor which determines breast cancer risk, and most women that get breast cancer don’t express genetic predisposition.

Fiction: If someone in your family has had Breast Cancer, you will inevitably get Breast Cancer yourself.

If someone in your family has experienced Breast Cancer in the past, this is vital information that your physician needs to know. In addition to knowing that you have a history, it’s also important for your physician to know how many women in your family have experienced the condition in the past. Although Breast Cancer risk increases significantly when your family has a prior history of the condition, this doesn’t mean that you will definitely get breast cancer in the future.

There are ways to establish your risk, including genetic testing and counseling. One of the issues with how Breast Cancer risk is evaluated these days is that not enough women get these tests done. In fact, the percentage of women that actually receive this analysis is in the single digits! As with many other conditions, patients simply aren’t open enough with their doctors, and many doctors don’t readily recommend such procedures without prompting.

If your genetic evaluation says that you are at an elevated risk of Breast Cancer, this can completely change the way that your physician handles your Breast Cancer Prevention and Monitoring. For example, women at high risk benefit from earlier screening, both in the form of mammograms and MRI scanning. Breast Cancer, when caught early, has a very high rate of successful treatment, and by catching it early, it can be removed and treated before it has the chance to significantly risk your health. There are even preventative treatments available, ranging from surgery to pharmaceuticals that can be used to mitigate your breast cancer risk, dependent on your risk level.

Truth: Women with a family history shouldn’t think of breast cancer as inevitable, but they should take the steps to ensure their health and safety. With proper care and screening, Breast Cancer can usually be prevented or defeated before it reaches its more dangerous stages.

Fiction: Women without a history or genetic disposition toward breast cancer have nothing they can do to mitigate their potential risk for the condition.

Some variables of Breast Cancer risk are incontrovertible. There’s nothing you can do about your age, or your family history. There’s nothing you can do to change when you enter puberty or reach menopause. On the other hand, there are a variety of factors that you do have the power to mitigate, and you can take an active role in your breast cancer prevention. The following are three factors to think about in particular: Activity Level, Body Composition, and Alcohol Consumption.

Activity Level – A sedentary lifestyle has been scientifically shown to increase Breast Cancer risk. Studies have shown that women that get a lot of physical activity every day have a 25% reduced breast cancer risk as compared to their counterparts that are largely sedentary. The ideal level of cardiovascular exercise in order to mitigate breast cancer risk is between 45 minutes and an hour per day, although less activity also promotes breast health. Ideally, women should undergo fairly vigorous exercise, such as swimming, cycling, or jogging. As little as 75 minutes of light cardio per week has the potential to reduce the risk of breast cancer by around 18%, however.

Bodyfat percentage has been strongly correlated to the risk of breast cancer in women (and men). This is even more true after Menopause. As you experience your regular periods, the ovaries are primarily responsible for the production of Estrogen, whereas adipose fat tissue produces much less. After a woman’s Ovaries stop producing Estrogen at menopause, however, the body primarily relies on fat cells to produce the hormone. The amount of Estrogen that a woman produces via her body fat correlates completely with the amount of body fat she carries. Abnormally high Estrogen Levels increase breast tissue activity, which further correlates to breast cancer risk.

Alcohol Consumption – It is well documented that Alcohol suppresses Testosterone production in men by increasing the rate at which Testosterone is converted into Estrogen. Alcohol consumption also leads to an increase in breast cancer risk as well, as a result of increasing Estrogen levels in the blood stream. Specifically, each drink that a women consumes daily is associated with an increased risk of Breast Cancer of between ten and twelve percent. In addition, high levels of Alcohol consumption are also associated with other cancers such as liver, esophagus, throat, and mouth cancer.

For women that drink alcohol, the American Cancer Society suggests no more than one per day. To minimize Breast Cancer risk associated with Alcohol, it’s best to not drink at all.

Truth – Lifestyle factors play a major role in cancer risk, and by improving your lifestyle, you can reduce the odds of experiencing Breast Cancer in the future.

Fiction – Injuring your breast can cause breast cancer.

Many women are under the mistaken notion that hurting one’s breast can cause breast cancer. There is no evidence that bruising breast tissue can cause breast cancer. The reason that this myth first began to circulate is likely because bruising or pain in the particular area of the breast occasionally brings existing cancers to the notice of patient or physician. In these cases, the tumor has existed for awhile, but simply hasn’t been noticed.

Truth – You can’t get cancer from breast bruises.

Fiction – Breast Cancer is a disease which only occurs to women.

In reality, both sexes can get breast cancer. The reason why so many people think that men can’t get breast cancer is because it is far more rare than female breast cancer. In fact, women get breast cancer at a rate which is a hundred times that of their male counterpart. On average, only around 2,200 men in the United States get breast cancer, whereas 230,000 women experience the disease. The mortality rates differ similarly: 400 males die each year from the condition, whereas 40,000 women die from breast cancer.

That men are not made aware of male breast cancer can be to the detriment of their health. Because they don’t understand that men can get breast cancer, they frequently recognize the lumps, but simply ignore them until they become impossible to ignore, a point at which the danger of the cancer has grown dramatically and the outlook becomes far more grim.

Women have a higher incidence of breast cancer for a couple of important reasons. First, most cancers respond to progesterone and/or estrogen, feeding off of the hormones to grow. Since men don’t produce nearly as much, their risk is significantly lower. Also, men have fewer breast cells than women, meaning that there are fewer possible cells to malfunction.

Truth – Although men experience breast cancer at a much lower rate, they should still see their doctor if they sense any breast tissue abnormalities.

Fiction – The ideal way to catch breast cancer is with monthly self-exams

Not too long ago, it was recommended that women give themselves monthly evaluations to check for breast lumps and other abnormalities, but this is no longer the recommended protocol of the American Cancer Society. They discovered that these examinations increased the rate of false positives while also not being all too effective at discovering real cancer. Instead, the current suggestion is simply to have knowledge of one’s body, and be aware of any abnormal changes take place. The majority of women discover Breast Cancer during their normal routine, and an emphasis on awareness during routine appears to provide the best detection results.

Of course, women that are still interested in performing these monthly exams still may do so if they wish, but it is important that they learn how to perform the exams with maximum accuracy, as taught by their physician, if they wish to perform the self-exam in an optimal fashion.

If a woman feels a lump or recognizes any breast abnormalities, it is vital to talk to one’s physician as soon as possible. Even if you have recently had a mammogram performed, it’s still possible that the exam missed a potential cancer. It’s important to not only engage in self-examination, but also to undergo Mammogram, because often, Breast Cancer tumors can be recognized before they are felt, and the earlier that Breast Cancer is treated, the more likely it can be safely removed and treated completely.

Truth – There’s nothing wrong with monthly breast exams, but regular, breast awareness is more than sufficient to recognize potential breast cancer.

Fiction – Finding lumps is the only indication of Breast Cancer

All women understand that breast cancer can lead to tumors, which are referred to as lumps, but many women are unaware of other symptoms which are indicative of Breast Cancer which can be recognized, other than lumps. For example, unnatural breast discharge, scaliness and redness of the breast or nipple, pain and extreme sensitivity, dimpling, and irritation can all be signs of Breast Cancer. Some women may even experience an inversion of the nipple.

In fact, one rare but particularly dangerous type of breast cancer, known as Inflammatory Breast Cancer, is characterized by swelling, thickened skin, and redness, rather than lumps. Never assume that changes in breast health are benign or simply caused by infection. Visit a physician as soon as you can.

Truth – Lumps are the most commonly recognized symptom, but different cancers have different symptoms, and you should always take the proper precautions and make an appointment with a medical professional at the first sign of breast trouble.

Fiction – Mammograms Are Barely Worth the Time

Some women, unfortunately, have lost their faith in the effectiveness of the mammogram. In reality, mammograms are quite effective at recognizing breast cancer, with a success rate of between 80% and 90%. There’s no data which can accurately reflect how Mammograms mitigate mortality risk, but there is near universal agreement that Mammograms save women’s live on a regular basis. The general consensus is that when women turn forty, they should start getting yearly Mammograms.

Truth – Mammograms are an effective means to monitor for breast cancer.

Fiction – Deodorants Can Cause Breast Cancer

There are websites and emails which claim that Deodorants and Antiperspirants have the ability to cause breast cancer, by inhibiting immune function by blocking the lymph nodes. By inhibiting immune function, they supposedly increase toxin concentrations in the breast tissue There is next to no evidence that suggests that this is even a possibility.

One major study surveyed whether women with and without breast cancer used deodorant, in an attempt to see if there was any correlation with the use of such products and breast cancer. No significant connection was found. Shaving also had no notable impact on breast cancer rate.

Truth – Antiperspirants have absolutely zero noted connection with Breast Cancer.

Posted in Breast Cancer | Comments Off

Stem Cell Conferences | Cell and Stem Cell Congress | Stem …

On behalf of the organizing committee, it is my distinct pleasure to invite you to attend the Stem Cell Congress-2017. After the success of the Cell Science-2011, 2012, 2013, 2014, 2015, Conference series.LLC is proud to announce the 6th World Congress and expo on Cell & Stem Cell Research (Stem Cell Congress-2017) which is going to be held during March 20-22, 2017, Orlando, Florida, USA. The theme of Stem Cell Congress-2017 is Explore and Exploit the Novel Techniques in Cell and Stem Cell Research.

This annual Cell Science conference brings together domain experts, researchers, clinicians, industry representatives, postdoctoral fellows and students from around the world, providing them with the opportunity to report, share, and discuss scientific questions, achievements, and challenges in the field.

Examples of the diverse cell science and stem cell topics that will be covered in this comprehensive conference include Cell differentiation and development, Cell metabolism, Tissue engineering and regenerative medicine, Stem cell therapy, Cell and gene therapy, Novel stem cell technologies, Stem cell and cancer biology, Stem cell treatment, Tendency in cell biology of aging and Apoptosis and cancer disease, Drugs and clinical developments. The meeting will focus on basic cell mechanism studies, clinical research advances, and recent breakthroughs in cell and stem cell research. With the support of many emerging technologies, dramatic progress has been made in these areas. In Stem Cell Congress-2017, you will be able to share experiences and research results, discuss challenges encountered and solutions adopted and have opportunities to establish productive new academic and industry research collaborations.

In association with the Stem Cell Congress-2017 conference, we will invite those selected to present at the meeting to publish a manuscript from their talk in the journal Cell Science with a significantly discounted publication charge. Please join us in Philadelphia for an exciting all-encompassing annual Stem Cell get together with the theme of better understanding from basic cell mechanisms to latest Stem Cell breakthroughs!

Haval Shirwan, Ph.D. Executive Editor, Journal of Clinical & Cellular Immunology Dr. Michael and Joan Hamilton Endowed Chair in Autoimmune Disease Professor, Department of Microbiology and Immunology Director, Molecular Immunomodulation Program, Institute for Cellular Therapeutics, University of Louisville, Louisville, KY

Track01:Stem Cells

The most well-established and widely used stem cell treatment is thetransplantationof blood stem cells to treat diseases and conditions of the blood and immune system, or to restore the blood system after treatments for specific cancers. Since the 1970s,skin stem cellshave been used to grow skin grafts for patients with severe burns on very large areas of the body. Only a few clinical centers are able to carry out this treatment and it is usually reserved for patients with life-threatening burns. It is also not a perfect solution: the new skin has no hair follicles or sweat glands. Research aimed at improving the technique is ongoing.

Related Stem Cell Conferences|Stem Cell Congress|Cell and Stem Cell Conferences|Conference Series LLC

7thAnnual Conference on Stem Cell and Regenerative MedicineAug 4-5, 2016, Manchester, UK;2nd InternationalConference on AntibodiesJuly 14-15, 2016 Philadelphia, USA; 2nd InternationalConference on Innate ImmunityJuly 21-22, 2016 Berlin, Germany; 2ndInternational Congress on Neuroimmunology March 31-April 02, 2016 Atlanta, USA; InternationalConference on Cancer Immunology July 28-30, 2016 Melbourne, Australia; 5th InternationalConference on ImmunologyOctober 24-26, 2016 Chicago, USA;Cancer Vaccines: Targeting Cancer Genes for Immunotherapy, Mar 610 2016, Whistler, Canada;Systems Immunology: From Molecular Networks to Human Biology, Jan 1014 2016, Big Sky, USA;Novel Immunotherapeutics Summit, Jan 2526 2016, San Diego, USA;Stromal Cells in Immunity, Feb 711 2016, Keystone, USA; 26th European Congress ofClinical Microbiology, April 912 2016, Istanbul, Turkey

Track 02: Stem Cell Banking:

Stem Cell Banking is a facility that preserves stem cells derived from amniotic fluid for future use. Stem cell samples in private or family banks are preserved precisely for use by the individual person from whom such cells have been collected and the banking costs are paid by such person. The sample can later be retrieved only by that individual and for the use by such individual or, in many cases, by his or her first-degree blood relatives.

Related Stem Cell Conferences|Stem Cell Congress|Cell and Stem Cell Conferences|Conference Series LLC

8thWorld Congress on Stem Cell ResearchMarch 20-22, 2017 Orlando, USAInternationalConference on Cancer ImmunologyJuly 28-30, 2016 Melbourne, Australia; 5th InternationalConference on ImmunologyOctober 24-26, 2016 Chicago, USA;Cancer Vaccines: Targeting Cancer Genes for Immunotherapy, Mar 610 2016, Whistler, Canada;Systems Immunology: From Molecular Networks to Human Biology, Jan 1014 2016, Big Sky, USA;Novel Immunotherapeutics Summit, Jan 2526 2016, San Diego, USA;Stromal Cells in Immunity, Feb 711 2016, Keystone, USA; 26th European Congress ofClinical Microbiology, April 912 2016, Istanbul, Turkey

Track 03: Stem Cell Therapy:

Autologous cells are obtained from one’s own body, just as one may bank his or her own blood for elective surgical procedures. Adult stem cells are frequently used in medical therapies, for example in bone marrow transplantation. Human embryonic stem cells may be grown in vivo and stimulated to produce pancreatic -cells and later transplanted to the patient. Its success depends on response of the patients immune system and ability of the transplanted cells to proliferate, differentiate and integrate with the target tissue.

Related Stem Cell Conferences|Stem Cell Congress|Cell and Stem Cell Conferences|Conference Series LLC

4th InternationalConference on Plant GenomicsJuly 14-15, 2016 Brisbane, Australia; 8thWorld Congress on Stem Cell ResearchMarch 20-22, 2017 Orlando, USA; 7thAnnual Conference on Stem Cell and Regenerative MedicineAug 4-5, 2016, Manchester, UK; 2nd InternationalConference on Tissue preservation and BiobankingSeptember 12-13, 2016 Philadelphia, USA, USA;World Congress on Human GeneticsOctober 31- November 02, 2016 Valencia, Spain; 12thEuro Biotechnology CongressNovember 7-9, 2016 Alicante, Spain; 2nd InternationalConference on Germplasm of Ornamentals, Aug 8-12, 2016, Atlanta, USA; 7th Internationalconference on Crop Science, Aug 1419 2016, Beijing, China;Plant Epigenetics: From Genotype to Phenotype, Feb 1519 2016, Taos, USA;Germline Stem Cells Conference, June 1921 2016, San Francisco, USA;Conference on Water Stressin Plants, 29 May 3 June 2016, Ormont-Dessus, Switzerland

Track 04: Novel Stem Cell Technologies:

Stem cell technology is a rapidly developing field that combines the efforts of cell biologists, geneticists, and clinicians and offers hope of effective treatment for a variety of malignant and non-malignant diseases. Stem cells are defined as totipotent progenitor cells capable of self-renewal and multilineage differentiation. Stem cells survive well and show stable division in culture, making them ideal targets for in vitro manipulation. Although early research has focused on haematopoietic stem cells, stem cells have also been recognised in other sites. Research into solid tissue stem cells has not made the same progress as that on haematopoietic stem cells.

Related Stem Cell Conferences|Stem Cell Congress|Cell and Stem Cell Conferences|Conference Series LLC

InternationalConference on Next Generation SequencingJuly 21-22, 2016 Berlin, Germany; 5th InternationalConference on Computational Systems BiologyAugust 22-23, 2016 Philadelphia, USA; 7th InternationalConference on BioinformaticsOctober 27-28, 2016 Chicago, USA; InternationalConference on Synthetic BiologySeptember 28-30, 2015 Houston, USA; 4th InternationalConference on Integrative BiologyJuly 18-20, 2016 Berlin, Germany; 1st InternationalConference on Pharmaceutical BioinformaticsJan 2426 2016, Pattaya, Thailand; EMBL Conference: TheEpitranscriptome, Apr 2022 2016, Heidelberg, Germany; 2016Whole-Cell ModelingSummer School, Apr 38 2016, Barcelona, Spain; 3rd InternationalMolecular Pathological Epidemiology, May 1213 2016, Boston, USA; 5thDrug FormulationSummit, Jan 2527 2016, Philadelphia, USA

Track 05: Stem Cell Treatment:

Bone marrow transplant is the most extensively used stem-cell treatment, but some treatment derived from umbilical cord blood are also in use. Research is underway to develop various sources for stem cells, and to apply stem-cell treatments for neurodegenerative diseases and conditions, diabetes, heart disease, and other conditions.

Related Stem Cell Conferences|Stem Cell Congress|Cell and Stem Cell Conferences|Conference Series LLC

7th InternationalConference on BioinformaticsOctober 27-28, 2016 Chicago, USA; InternationalConference on Synthetic BiologySeptember 28-30, 2015 Houston, USA; 7thAnnual Conference on Stem Cell and Regenerative MedicineAug 4-5, 2016, Manchester, UK; 4th InternationalConference on Integrative BiologyJuly 18-20, 2016 Berlin, Germany; 1st InternationalConference on Pharmaceutical BioinformaticsJan 2426 2016, Pattaya, Thailand; EMBL Conference: TheEpitranscriptome, Apr 2022 2016, Heidelberg, Germany; 2016Whole-Cell ModelingSummer School, Apr 38 2016, Barcelona, Spain; 3rd InternationalMolecular Pathological Epidemiology, May 1213 2016, Boston, USA; 5thDrug FormulationSummit, Jan 2527 2016, Philadelphia, USA

Track 06: Stem cell apoptosis and signal transduction:

Apoptosis is the process of programmed cell death (PCD) that may occur in multicellular organisms. Biochemical events lead to characteristic cell changes (morphology) and death. These changes include blebbing, cell shrinkage, nuclear fragmentation, chromatin condensation, chromosomal DNA fragmentation, and global mRNA decay. Most cytotoxic anticancer agents induce apoptosis, raising the intriguing possibility that defects in apoptotic programs contribute to treatment failure. Because the same mutations that suppress apoptosis during tumor development also reduce treatment sensitivity, apoptosis provides a conceptual framework to link cancer genetics with cancer therapy.

Related Stem Cell Conferences|Stem Cell Congress|Cell and Stem Cell Conferences|Conference Series LLC

InternationalConference on Restorative MedicineOctober 24-26, 2016 Chicago, USA;; 3rdWorld Congress onHepatitis and Liver Diseases October 17-19, 2016 Dubai, UAE; InternationalConference on Molecular BiologyOctober 13-15, 2016 Dubai, UAE; 2nd InternationalConference on Tissue preservation and Biobanking September12-13, 2016 Philadelphia USA; 26thEuropean Congress ofClinical Microbiology, April 912 2016, Istanbul, Turkey;Conference onCell Growth and Regeneration, Jan 1014 2016, Breckenridge, USA ;

Track 07: Stem Cell Biomarkers:

Molecular biomarkers serve as valuable tools to classify and isolate embryonic stem cells (ESCs) and to monitor their differentiation state by antibody-based techniques. ESCs can give rise to any adult cell type and thus offer enormous potential for regenerative medicine and drug discovery. A number of biomarkers, such as certain cell surface antigens, are used to assign pluripotent ESCs; however, accumulating evidence suggests that ESCs are heterogeneous in morphology, phenotype and function, thereby classified into subpopulations characterized by multiple sets of molecular biomarkers.

Related Stem Cell Conferences|Stem Cell Congress|Cell and Stem Cell Conferences|Conference Series LLC

8thWorld Congress on Stem Cell ResearchMarch 20-22, 2017 Orlando, USA; 5th International Conference onCell and Gene TherapyMay 19-21, 2016 San Antonio, USA; 7thAnnual Conference on Stem Cell and Regenerative MedicineAug 4-5, 2016, Manchester, UK; InternationalConference on Restorative MedicineOctober 24-26, 2016 Chicago, USA; InternationalConference on Molecular BiologyOctober 13-15, 2016 Dubai, UAE; 2nd InternationalConference on Tissue preservation and Biobanking September12-13, 2016 Philadelphia USA;Conference on Cardiac Development, Regeneration and RepairApril 3 7, 2016 Snowbird, Utah, USA; Stem Cell DevelopmentMay 22-26, 2016 Hillerd, Denmark; Conference onHematopoietic Stem Cells, June 3-5, 2016 Heidelberg, Germany; ISSCR Pluripotency – March 22-24, 2016 Kyoto, Japan

Track 08: Cellular therapies:

Cellular therapy also called Cell therapy is therapy in which cellular material is injected into a patient, this generally means intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy.

Related Stem Cell Conferences|Stem Cell Congress|Cell and Stem Cell Conferences|Conference Series LLC

InternationalConference on Genetic Counseling and Genomic MedicineAugust 11-12, 2016 Birmingham, UK;World Congress on Human GeneticsOctober 31- November 02, 2016 Valencia, Spain; InternationalConference on Molecular BiologyOctober 13-15, 2016 Dubai, UAE; 3rd InternationalConference on Genomics & PharmacogenomicsSeptember 21-23, 2015 San Antonio, USA; EuropeanConference on Genomics and Personalized MedicineApril 25-27, 2016 Valencia, Spain;Genomics and Personalized Medicine, Feb 711 2016, Banff, Canada; Drug Discovery for Parasitic Diseases, Jan 2428 2016, Tahoe City, USA; Heart Failure: Genetics,Genomics and Epigenetics, April 37 2016, Snowbird, USA; Understanding the Function ofHuman Genome Variation, May 31 June 4 2016, Uppsala, Sweden; 5thDrug Formulation SummitJan2527,2016,Philadelphia, USA

Track 09: Stem cells and cancer:

Cancer can be defined as a disease in which a group of abnormal cells grow uncontrollably by disregarding the normal rules of cell division. Normal cells are constantly subject to signals that dictate whether the cells should divide, differentiate into another cell or die. Cancer cells develop a degree of anatomy from these signals, resulting in uncontrolled growth and proliferation. If this proliferation is allowed to continue and spread, it can be fatal.

Related Stem Cell Conferences|Stem Cell Congress|Cell and Stem Cell Conferences|Conference Series LLC

2ndWorld Congress on Applied MicrobiologyOctober 31-November 02, 2016 Istanbul, Turkey; InternationalConference on Infectious Diseases & Diagnostic MicrobiologyOct 3-5, 2016 Vancouver, Canada;18th International conference on Neuroscience, April 26 2016, Sweden, Austria; 6th Annual Traumatic Brain Injury Conference, May 1112 2016, Washington, D.C., USA; Common Mechanisms of Neurodegeneration, June 1216 2016, Keystone, USA; Neurology Caribbean Cruise, Aug 2128 2016, Fort Lauderdale, USA; Annual Meeting of the German Society ofNeurosurgery(DGNC), June 1215 2016, Frankfurt am Main, Germany

Track 10: Embryonic stem cells:

Embryonic stem cells have a major potential for studying early steps of development and for use in cell therapy. In many situations, however, it will be necessary to genetically engineer these cells. A novel generation of lentivectors which permit easy genetic engineering of mouse and human embryonic stem cells.

Related Stem Cell Conferences|Stem Cell Congress|Cell and Stem Cell Conferences|Conference Series LLC

4thCongress on Bacteriology and Infectious DiseasesMay 16-18, 2016 San Antonio, USA; 2ndWorld Congress on Applied MicrobiologyOctober 31-November 02, 2016 Istanbul, Turkey; InternationalConference on Infectious Diseases & Diagnostic MicrobiologyOct 3-5, 2016 Vancouver, Canada; InternationalConference on Water MicrobiologyJuly 18-20, 2016 Chicago, USA; 5th InternationalConference on Clinical MicrobiologyOctober 24-26, 2016 Rome, Italy; Axons: FromCell Biologyto Pathology Conference, 2427 January 2016, Santa Fe, USA; 26th EuropeanCongress of Clinical MicrobiologyApril 912 2016, Istanbul, Turkey;Conference on Gut Microbiota, Metabolic Disorders and Beyond, April 1721 2016, Newport, USA; 7th EuropeanSpores Conference, April 1820 2016, Egham, UK; New Approaches to Vaccines forHuman and Veterinary Tropical Diseases, May 2226 2016, Cape Town, South Africa

Track 11: Cell differentiation and disease modeling:

Cellular differentiation is the progression, whereas a cell changes from one cell type to another. Variation occurs numerous times during the development of a multicellular organism as it changes from a simple zygote to a complex system of tissues and cell types. Differentiation continues in adulthood as adult stem cells divide and create fully differentiated daughter cells during tissue repair and during normal cell turnover. Some differentiation occurs in response to antigen exposure. Differentiation dramatically changes a cell’s size, shape, membrane potential, metabolic activity, and responsiveness to signals. These changes are largely due to highly controlled modifications in gene expression and are the study of epigenetics. With a few exceptions, cellular differentiationalmost never involves a change in the DNA sequence itself. Thus, different cells can have very different physical characteristics despite having the same genome.

Related Stem Cell Conferences|Stem Cell Congress|Cell and Stem Cell Conferences|Conference Series LLC

4thCongress on Bacteriology and Infectious DiseasesMay 16-18, 2016 San Antonio, USA; 2ndWorld Congress on Applied MicrobiologyOctober 31-November 02, 2016 Istanbul, Turkey; InternationalConference on Infectious Diseases & Diagnostic MicrobiologyOct 3-5, 2016 Vancouver, Canada; InternationalConference on Water MicrobiologyJuly 18-20, 2016 Chicago, USA; 5thInternationalConference on Clinical MicrobiologyOctober 24-26, 2016 Rome, Italy; Axons: FromCell Biologyto Pathology Conference, 2427 January 2016, Santa Fe, USA; 26thEuropeanCongress of Clinical MicrobiologyApril 912 2016, Istanbul, Turkey;Conference on Gut Microbiota, Metabolic Disorders and Beyond, April 1721 2016, Newport, USA; 7thEuropeanSpores Conference, April 1820 2016, Egham, UK; New Approaches toVaccines forHuman and Veterinary Tropical Diseases, May 2226 2016, Cape Town, South Africa

Track 12: Tissue engineering:

Tissue Engineering is the study of the growth of new connective tissues, or organs, from cells and a collagenous scaffold to produce a fully functional organ for implantation back into the donor host. Powerful developments in the multidisciplinary field of tissue engineering have produced a novel set of tissue replacement parts and implementation approaches. Scientific advances in biomaterials, stem cells, growth and differentiation factors, and biomimetic environments have created unique opportunities to fabricate tissues in the laboratory from combinations of engineered extracellular matrices cells, and biologically active molecules.

Related Stem Cell Conferences|Stem Cell Congress|Cell and Stem Cell Conferences|Conference Series LLC

4thCongress on Bacteriology and Infectious DiseasesMay 16-18, 2016 San Antonio, USA; 2ndWorld Congress on Applied MicrobiologyOctober 31-November 02, 2016 Istanbul, Turkey; InternationalConference on Infectious Diseases & Diagnostic MicrobiologyOct 3-5, 2016 Vancouver, Canada; InternationalConference on Water MicrobiologyJuly 18-20, 2016 Chicago, USA; 5thInternationalConference on Clinical MicrobiologyOctober 24-26, 2016 Rome, Italy; Axons: FromCell Biologyto Pathology Conference, 2427 January 2016, Santa Fe, USA; 26thEuropeanCongress of Clinical MicrobiologyApril 912 2016, Istanbul, Turkey;Conference on Gut Microbiota, Metabolic Disorders and Beyond, April 1721 2016, Newport, USA; 7thEuropeanSpores Conference, April 1820 2016, Egham, UK; New Approaches toVaccines forHuman and Veterinary Tropical Diseases, May 2226 2016, Cape Town, South Africa

Track 13: Stem cell plasticity and reprogramming:

Stem cell plasticity denotes to the potential of stem cells to give rise to cell types, previously considered outside their normal repertoire of differentiation for the location where they are found. Included under this umbrella title is often the process of transdifferentiation the conversion of one differentiated cell type into another, and metaplasia the conversion of one tissue type into another. From the point of view of this entry, some metaplasias have a clinical significance because they predispose individuals to the development of cancer.

Related Stem Cell Conferences|Stem Cell Congress|Cell and Stem Cell Conferences|Conference Series LLC

InternationalConference on Case ReportsMarch 31-April 02, 2016 Valencia, Spain; 2nd International Meeting onClinical Case ReportsApril 18-20, 2016 Dubai, UAE; 3rd Experts Meeting onMedical Case ReportsMay 09-11, 2016 New Orleans, Louisiana, USA; 12thEuro BiotechnologyCongress November 7-9, 2016 Alicante, Spain; 2nd International Conference onTissue preservation and BiobankingSeptember 12-13, 2016 Philadelphia, USA; 11thWorld Conference BioethicsOctober 20-22, 2015 Naples, Italy;Annual Conference Health Law and Bioethics, May 6-7 2016 Cambridge, MA, USA; 27th Maclean Conference on Clinical Medical Ethics, Nov 13-14, 2015, Chicago, USA; CFP: Global Forum on Bioethics in Research, Nov 3-4, 2015, Annecy, France

Track 14: Gene therapy and stem cells

Gene therapy is the therapeutic delivery of nucleic acid polymers into a patient’s cells as a drug to treat disease. Gene therapy could be a way to fix a genetic problem at its source. The polymers are either expressed as proteins, interfere with protein expression, or possibly correct genetic mutations. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient’s cells instead of using drugs or surgery.

Related Stem Cell Conferences|Stem Cell Congress|Cell and Stem Cell Conferences|Conference Series LLC

Track 15: Tumour cell science:

An abnormal mass of tissue. Tumors are a classic sign of inflammation, and can be benign or malignant. Tomour usually reflect the kind of tissue they arise in. Treatment is also specific to the location and type of the tumor. Benign tumors can sometimes simply be ignored, cancerous tumors; options include chemotherapy, radiation, and surgery.

Related Stem Cell Conferences|Stem Cell Congress|Cell and Stem Cell Conferences|Conference Series LLC

Track 16: Reprogramming stem cells: computational biology

Computational Biology, sometimes referred to as bioinformatics, is the science of using biological data to develop algorithms and relations among various biological systems. Bioinformatics groups use computational methods to explore the molecular mechanisms underpinning stem cells. To accomplish this bioinformaticsdevelop and apply advanced analysis techniques that make it possible to dissect complex collections of data from a wide range of technologies and sources.

Related Stem Cell Conferences|Stem Cell Congress|Cell and Stem Cell Conferences|Conference Series LLC

The fields of stem cell biology and regenerative medicine research are fundamentally about understanding dynamic cellular processes such as development, reprogramming, repair, differentiation and the loss, acquisition or maintenance of pluripotency. In order to precisely decipher these processes at a molecular level, it is critical to identify and study key regulatory genes and transcriptional circuits. Modern high-throughput molecular profiling technologies provide a powerful approach to addressing these questions as they allow the profiling of tens of thousands of gene products in a single experiment. Whereas bioinformatics is used to interpret the information produced by such technologies.

Related Stem Cell Conferences|Stem Cell Congress|Cell and Stem Cell Conferences|Conference Series LLC

8th World Congress on Cell & Stem Cell Research

The success of the 7 Cell Science conferences series has given us the prospect to bring the gathering one more time for our 8thWorld Congress 2017 meet in Orlando, USA. Since its commencement in 2011 cell science series has perceived around 750 researchers of great potentials and outstanding research presentations around the globe. The awareness of stem cells and its application is increasing among the general population that also in parallel offers hope and add woes to the researchers of cell science due to the potential limitations experienced in the real-time.

Stem Cell Research-2017has the goal to fill the prevailing gaps in the transformation of this science of hope to promptly serve solutions to all in the need.World Congress 2017 will have an anticipated participation of 100-120 delegates from around the world to discuss the conference goal.

History of Stem cells Research

Stem cells have an interesting history, in the mid-1800s it was revealed that cells were basically the building blocks of life and that some cells had the ability to produce other cells. Efforts were made to fertilize mammalian eggs outside of the human body and in the early 1900s, it was discovered that some cells had the capacity to generate blood cells. In 1968, the first bone marrow transplant was achieved successfully to treat two siblings with severe combined immunodeficiency. Other significant events in stem cell research include:

1978: Stem cells were discovered in human cord blood 1981: First in vitro stem cell line developed from mice 1988: Embryonic stem cell lines created from a hamster 1995: First embryonic stem cell line derived from a primate 1997: Cloned lamb from stem cells 1997: Leukaemia origin found as haematopoietic stem cell, indicating possible proof of cancer stem cells

Funding in USA:

No federal law forever did embargo stem cell research in the United States, but only placed restrictions on funding and use, under Congress’s power to spend. By executive order on March 9, 2009, President Barack Obama removed certain restrictions on federal funding for research involving new lines of humanembryonic stem cells. Prior to President Obama’s executive order, federal funding was limited to non-embryonic stem cell research and embryonic stem cell research based uponembryonic stem celllines in existence prior to August 9, 2001. In 2011, a United States District Court “threw out a lawsuit that challenged the use of federal funds for embryonic stem cell research.

Members Associated with Stem Cell Research:

Discussion on Development, Regeneration, and Stem Cell Biology takes an interdisciplinary approach to understanding the fundamental question of how a single cell, the fertilized egg, ultimately produces a complex fully patterned adult organism, as well as the intimately related question of how adult structures regenerate. Stem cells play critical roles both during embryonic development and in later renewal and repair. More than 65 faculties in Philadelphia from both basic science and clinical departments in the Division of Biological Sciences belong to Development, Regeneration, and Stem Cell Biology. Their research uses traditional model species including nematode worms, fruit-flies, Arabidopsis, zebrafish, amphibians, chick and mouse as well as non-traditional model systems such as lampreys and cephalopods. Areas of research focus include stem cell biology, regeneration, developmental genetics, and cellular basis of development, developmental neurobiology, and evo-devo (Evolutionary developmental biology).

Stem Cell Market Value:

Worldwide many companies are developing and marketing specialized cell culture media, cell separation products, instruments and other reagents for life sciences research. We are providing a unique platform for the discussions between academia and business.

Global Tissue Engineering & Cell Therapy Market, By Region, 2009 2018

$Million

Why to attend???

Stem Cell Research-2017 could be an outstanding event that brings along a novel and International mixture of researchers, doctors, leading universities and stem cell analysis establishments creating the conference an ideal platform to share knowledge, adoptive collaborations across trade and world, and assess rising technologies across the world. World-renowned speakers, the most recent techniques, tactics, and the newest updates in cell science fields are assurances of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://stemcell.omicsgroup.com/sponsors.php

UAS Major Universities which deals with Stem Cell Research

University of Washington/Hutchinson Cancer Center

Oregon Stem Cell Center

University of California Davis

University of California San Francisco

University of California Berkeley

Stanford University

Mayo Clinic

Major Stem Cell Organization Worldwide:

Norwegian Center for Stem Cell Research

Read more here:
Stem Cell Conferences | Cell and Stem Cell Congress | Stem …

Posted in Stem Cell Cancer | Comments Off

Your Breast Cancer Diagnosis | Breastcancer.org

Just as no two people are exactly alike, no two breast cancers are exactly the same, either. Your doctor will order a series of tests on the cancer and nearby tissues to create a profile of how the breast cancer looks and behaves. Some of these tests are done after the initial biopsy (removal of tissue sample for testing), others in the days and weeks after lumpectomy or mastectomy. Each time testing is done, your doctor receives a report of results from the laboratory. All of these lab reports together make up your complete pathology report.

Your pathology report is so important because it provides information you and your doctor need to make the best treatment choices for your particular diagnosis. Those decisions depend on knowing characteristics such as:

In this section you can read more about what your pathology report is likely to include and what the information means. If youve already been diagnosed with breast cancer and you see a test here that doesnt appear in your report, dont worry not all of these tests are routine. Ask your doctor if youre concerned about any tests that werent performed on your tissue. The laboratory keeps your tissue samples for a long time after surgery, so testing can be done later in the process of diagnosis if necessary.

For more help understanding your diagnosis, you can also use My Breast Cancer Coach. My Breast Cancer Coach is a questionnaire designed to help you better understand your type of breast cancer so you can focus on the information that’s most relevant to you.

Visit the links below to learn about the different parts of your pathology report:

To connect with others who have been recently diagnosed, discuss experiences, and ask questions, visit the Breastcancer.org Discussion Board forum Just Diagnosed.

“The information in your pathology report often comes in bits and pieces. Just after surgery, the cancer cells are first looked at under the microscope. Results from additional studies that require special techniques may take longer. So you may have one, two, or three lab reports from one surgery. Together, the lab reports make up your pathology report. Try to keep all your reports in one place, so that when you go for your treatment evaluations, the doctors will have all the information they need.”

Go here to see the original:
Your Breast Cancer Diagnosis | Breastcancer.org

Posted in Breast Cancer | Comments Off

Cancer Treatment Baltimore | Oncology Center of Central …

More Than 30 Years in Practice

At The Oncology Center of Central Baltimore, we understand that being diagnosed with cancer is a frightening event that changes your life forever. Often, this diagnosis is unanticipated and suddenly puts you in need of support from those around you, financial guidance, and the advice of an expert medical team.

With more than 30 years of practice in the field of oncology, our expert team of oncologist in baltimore is proud to offer all these services and more. You don’t have to fight a battle with cancer alone. Call our office at (410) 662-6222 and schedule an appointment today!

We treat multiple types of cancers and blood disorders including:

At our center, we are proud to offer both individual and specialized care. Our staff firmly believes in taking a strong and active approach to fighting cancer. We stay up-to-date with the latest in cancer research, and offer state-of-the-art medicine and cancer treatment in Baltimore; all of which are specifically tailored to your individual situation. Dr. Stanley Walker is a leader in the field of oncology, as he not only treats patients, but teaches medical students and residents at the center, as well involved in clinical trials.

We are determined to provide the absolute best level of communication necessary to ensure you receive the highest-quality medical care possible. Dr. Walker is located at the same site as our treatment center and a nurse is assigned to you, and can be present at every treatment session and medical appointment. With this continuity of service, you can feel safe knowing you are in the hands of an experienced staff member who is familiar with your individualized treatment plan.

Have you recently been diagnosed with cancer and are living in the Baltimore or Washington D.C. metro area? At the Oncology Center of Central Baltimore, we are here to provide you with the cancer treatment and support you deserve. Contact our office at (410) 662-6222 and schedule an appointment with one of our expert staff members today!

Excerpt from:
Cancer Treatment Baltimore | Oncology Center of Central …

Posted in Oncology | Comments Off

Columbia Maryland Oncology Hematology

Maryland Oncology Hematology 10710 Charter Drive Suite G020 Columbia, Maryland 21044 Phone: 410-964-2212 Fax: 410-964-0380 Map

From the North: Take I-95 South toward Washington. Exit onto MD Route 175 West toward Columbia. Stay on Route 175 (which turns into Little Patuxent Parkway) for approximately 7 miles. Turn left onto Cedar Lane. Turn left onto Hickory Ridge Road. Turnleft onto Charter Drive.

We are in the second building on the right, located on theground floor of the Medical Pavilion at Howard County, suite G020. There islower level parking to the right of the main entrance.

From the South: Take US Route 29 North toward Columbia. Exit onto Broken Land Parkway toward Columbia Town Center/Merriweather Post Pavilion. Turn left onto Hickory Ridge Road. Turn right onto Charter Drive to the second building on the right, The Medical Pavilion at Howard County.

We are located on the ground floor, suite G020. There is lower level parking to the right of the main entrance.

Physicians for Columbia

Originally posted here:
Columbia Maryland Oncology Hematology

Posted in Oncology | Comments Off

Department of Radiation Oncology: University of Maryland …

For more than 50 years, the University of Maryland Department of Radiation Oncology has been caring for those whose lives have been threatened by a diagnosis of cancer.

Whether those patients live in Baltimore or travel from their homes around the world, they know that they will be receiving the finest of care, from the most state-of-the-art technology to the skilled and compassionate healing offered by every member of the Radiation Oncology faculty and staff.

Our department manages every type of cancer, providing a depth of experience that makes the University of Maryland not only the right place to receive care, but an ideal professional career as well. The extraordinary pace of our recent progress has resulted from intellectual synergy and a shared, relentless ambition to deliver the highest quality of care to patients.

The University of Maryland Department of Radiation Oncology has five locations:

Each site is staffed with University of Maryland faculty. This affiliation opens the door to leading-edge treatment modalities, cutting-edge clinical trials and expert consultation with University of Maryland Greenebaum Cancer Center physicians.

The University of Maryland School of Medicine and its development partner Advanced Particle Therapy LLC of San Diego, Calif., have begun construction on the Maryland Proton Treatment Center, a more than $200 million project that brings to Maryland for the first time the most advanced radiation technology in cancer treatment. Click on the banner above to find out more.

After four years of nagging throat and ear problems, Pat Tierney was diagnosed with Stage IV cancer at the base of her tongue in 2008. She traveled from her home in Kentucky to several cancer centers around the country for opinions before deciding to be treated by Dr. William Regine in the Department of Radiation Oncology at the University of Maryland Greenebaum Cancer Center in Baltimore. In this video, she shares the story of how she navigated a difficult diagnosis and treatment, including 17 months on a feeding tube, and how she has chosen to approach her life as a cancer survivor. Watch her story >>

Excellence in our educational mission is pursued through many avenues: the rotation of medical students through our program; our residency program, which includes eight residents; our radiation therapy program; and our dosimetry school, which is accredited by the Joint Review Committee on Education in Radiologic Technology (JRCERT). This program is only one of twelve programs in the United States to achieve such accreditation.

The Departments focus on promoting translational research includes integration of our radiobiology, physics and clinical divisions, as well as with the University of Maryland Marlene and Stewart Greenebaum Cancer Center and other basic science departments. Our physicians, physicists and basic science researchers are nationally recognized leaders in discovering new and better ways to treat cancer with radiotherapy.

As we move forward, our past present and future can be summarized by our Departmental Vision and Mission Statement:

It is who we are, it is what we do, it is what leaves us feeling there is more work to be done at the end of each day, and it is what drives us towards greater achievements at the start of each day.

Continued here:
Department of Radiation Oncology: University of Maryland …

Posted in Oncology | Comments Off

Stem cell propagation fuels cancer risk in different organs

August 25, 2016

The idea that stem cells – special cells that divide to repair and generate tissues – might be the major determinant of cancer risk has provoked great debate in the scientific community. Some researchers maintain that environmental carcinogens are more important in determining cancer risk. Now a team of researchers at St. Jude Children’s Research Hospital and the University of Cambridge, England, has performed a large systematic, organism-wide study that confirms the crucial contribution of stem cells to the origins of cancer in different organs of mice. The results appear online today in the journal Cell.

“The chance accrual of random mistakes in cell DNA likely plays an important role in generating cancer; but whether this has to happen in specific cell types, such as stem cells, and precisely how other factors such as environmental carcinogens contribute to cancer is unclear,” said the study’s senior author Richard Gilbertson, M.D., Ph.D., director of the Cancer Research UK Cancer Center at Cambridge University, England, and former St. Jude scientific and Comprehensive Cancer Center director. “Indeed, an argument has raged across the scientific community for some years now – some say cancer is ‘bad luck’ because mutations arise by chance in stem cells, while others argue environmental carcinogens are more important. This disagreement has arisen largely from the use of different mathematical models to look at existing human cancer and stem cell data, from which it is extremely difficult to tease out the impact of individual factors. Therefore, we tested these different opinions in actual experimental models that looked at the individual components that might drive cancer.”

The researchers used a specific “marker molecule” called Prom1 to map the activity of cells in different organs throughout the life of mice. In some organs, Prom1+ cells were mature, non-dividing cells that did not repair or regenerate the organ, but in a handful of organs these cells were highly active stem cells. “By following these Prom1+ cells in all the major organs in mice through their lifetime journey we were able to identify in which organs these cells were actively dividing stem cells,” said Liqin Zhu, Ph.D., a research associate at St. Jude and the first author of the study.

Once they had an organism-wide map of the function of these cells, the researchers introduced DNA mutations into these cells similar to the changes that occur in human cancers. “This approach does away with the need for carcinogens, removing them from the cancer equation and allowing us to test if the generative capacity of stem cells influenced cancer risk,” said Zhu. After a rigorous study lasting more than seven years and comprehensive statistical modeling of the results by Dr. Arzu Onar-Thomas at St. Jude, the clear answer was that only cells with stem cell activity make cancer.

“But that’s not the whole story,” said Gilbertson. “While we have shown that stem cell function is required to generate cancer, our study also revealed that damage to tissues such as the liver, the kind that can occur in humans, can ‘wake up’ sleeping stem cells, make them divide and massively increase cancer risk. Therefore, we propose that the origin of cancer lies in a ‘perfect storm’ that includes DNA mutations, stem cell function and tissue damage,” concluded Gilbertson

The scientists also showed that stem cells in newborn animals are far less likely to undergo malignant transformation compared to adult stem cells, which suggests that stem cells in the newborn are intrinsically resistant to the formation of tumors. “If this biology were to hold true in humans, then it may explain why cancer rates are many-fold lower in children than adults, despite the fact that childhood cancers accrue significant numbers of mutations that alter proteins, and the growth rates of organs peak in childhood,” said Zhu.

Many of the new cancer models described in the study bear striking similarities to human diseases and should provide a valuable resource for further biological and therapeutic studies.

Explore further: Cancer stem cell vaccine in development shows antitumor effect

More information: Further reading:

1. Tomasetti, C., and Vogelstein, B. (2015) Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 347, 78-81. 2. Wu, S., Powers, S., Zhu, W., and Hannun, Y.A. (2016) Substantial contribution of extrinsic risk factors to cancer development. Nature 529(7584): 43-47.

Scientists may have discovered a new paradigm for immunotherapy against cancer by priming antibodies and T cells with cancer stem cells, according to a study published in Cancer Research, a journal of the American Association …

Stem cells in the bone marrow constantly give rise to new blood cells and are responsible for the maintenance of all vital blood components. However, errors during proliferation can change stem cell properties and cause tumours …

Scientists have identified for the first time the ‘cell of origin’ – in other words, the first cell from which the cancer grows – in basal cell carcinoma, the most common form of skin cancer, and followed the chain of events …

Across many cancer types, obese patients fare worse than leaner patients. Now a University of Colorado Cancer Center study published in the journal Cell Stem Cell offers a compelling hypothesis why: researchers found that …

Our skin renews, heals wounds, and regenerates the hair that covers it thanks to a small group of stem cells. These cells continually produce new ones, which appear on the skin surface after a few days. A study led by ICREA …

Novel scaffolds are shown enabling cells to behave in a different but controlled way in vitro due to the presence of aligned, self-assembled ceramic nanofibers of an ultra-high anisotropy ratio augmented into graphene shells.

Researchers have created a new drug delivery system that could improve the effectiveness of an emerging concept in cancer treatment – to dramatically slow and control tumors on a long-term, sustained basis, not necessarily …

A team including the National Cancer Center (NCC), the RIKEN Center for Life Science Technologies (CLST), and Carna Biosciences Inc. has jointly announced the development of a novel small-molecule Wnt inhibitor named NCB-0846. …

Researchers have identified a mechanism in mice by which anticancer immune responses are inhibited within the lungs, a common site of metastasis for many cancers. This mechanism involves oxygen inhibition of the anticancer …

Scientists have demonstrated for the first time the ‘perfect storm’ of conditions that cells need to start forming cancer, helping to explain why some organs are more susceptible to developing the disease, according to a …

The idea that stem cells – special cells that divide to repair and generate tissues – might be the major determinant of cancer risk has provoked great debate in the scientific community. Some researchers maintain that environmental …

Internal conflict between cell types explains why the immune system struggles to recognize and attack pancreatic cancer. Curbing this infighting has the potential to make treatment more effective, according to a study led …

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

View post:
Stem cell propagation fuels cancer risk in different organs

Posted in Stem Cell Cancer | Comments Off

Types of Cancer Treatment: Chemotherapy – National Cancer …

Chemotherapy (also called chemo) is a type of cancer treatment that uses drugs to kill cancer cells.

Chemotherapy works by stopping or slowing the growth of cancer cells, which grow and divide quickly. Chemotherapy is used to:

Chemotherapy is used to treat many types of cancer. For some people, chemotherapy may be the only treatment you receive. But most often, you will have chemotherapy and other cancer treatments. The types of treatment that you need depends on the type of cancer you have, if it has spread and where, and if you have other health problems.

When used with other treatments, chemotherapy can:

Chemotherapy not only kills fast-growing cancer cells, but also kills or slows the growth of healthy cells that grow and divide quickly. Examples are cells that line your mouth and intestines and those that cause your hair to grow. Damage to healthy cells may cause side effects, such as mouth sores, nausea, and hair loss. Side effects often get better or go away after you have finished chemotherapy.

The most common side effect is fatigue, which is feeling exhausted and worn out. You can prepare for fatigue by:

There are many ways you can help manage chemotherapy side effects. For more information, see the section on side effects.

The cost of chemotherapy depends on:

Talk with your health insurance company about what services it will pay for. Most insurance plans pay for chemotherapy. To learn more, talk with the business office where you go for treatment. If you need financial assistance, there are organizations that may be able to help. To find such organizations, go to the National Cancer Institute database, Organizations that Offer Support Services and search for “financial assistance.” Or call toll-free 1-800-4-CANCER (1-800-422-6237) to ask for information on organizations that may help.

Chemotherapy may be given in many ways. Some common ways include:

Chemotherapy is often given through a thin needle that is placed in a vein on your hand or lower arm. Your nurse will put the needle in at the start of each treatment and remove it when treatment is over. IV chemotherapy may also be given through catheters or ports, sometimes with the help of a pump.

There are many different chemotherapy drugs. Which ones are included in your treatment plan depends mostly on:

You may receive chemotherapy during a hospital stay, at home, or as an outpatient at a doctors office, clinic, or hospital. Outpatient means you do not stay overnight. No matter where you go for chemotherapy, your doctor and nurse will watch for side effects and help you manage them. For more information on side effects and how to manage them, see the section on side effects.

Treatment schedules for chemotherapy vary widely. How often and how long you get chemotherapy depends on:

You may receive chemotherapy in cycles. A cycle is a period of chemotherapy treatment followed by a period of rest. For instance, you might receive chemotherapy every day for 1 week followed by 3 weeks with no chemotherapy. These 4 weeks make up one cycle. The rest period gives your body a chance to recover and build new healthy cells.

It is best not to skip a chemotherapy treatment. But, sometimes your doctor may change your chemotherapy schedule if you are having certain side effects. If this happens, your doctor or nurse will explain what to do and when to start treatment again.

Chemotherapy affects people in different ways. How you feel depends on:

Since everyone is different and people respond to chemotherapy in different ways, your doctor and nurses cannot know for sure how you will feel during chemotherapy.

You will see your doctor often. During these visits, she will ask you how you feel, do a physical exam, and order medical tests and scans. Tests might include blood tests. Scans might include MRI, CT, or PET scans.

You cannot tell if chemotherapy is working based on its side effects. Some people think that severe side effects mean that chemotherapy is working well, or that no side effects mean that chemotherapy is not working. The truth is that side effects have nothing to do with how well chemotherapy is fighting your cancer.

Chemotherapy can damage the healthy cells that line your mouth and intestines and cause eating problems. Tell your doctor or nurse if you have trouble eating while you are receiving chemotherapy. You might also find it helpful to speak with a dietitian. For more information about coping with eating problems see the booklet Eating Hints or the section on side effects.

Many people can work during chemotherapy, as long as they match their work schedule to how they feel. Whether or not you can work may depend on what kind of job you have. If your job allows, you may want to see if you can work part-time or from home on days you do not feel well. Many employers are required by law to change your work schedule to meet your needs during cancer treatment. Talk with your employer about ways to adjust your work during chemotherapy. You can learn more about these laws by talking with a social worker.

Read more:
Types of Cancer Treatment: Chemotherapy – National Cancer …

Posted in Cancer Treatment | Comments Off

Cancer (Oncology) | Florida Hospital

As one of Floridas most comprehensive oncology programs, we treat more newly diagnosed cancer patients than any other health care system in the state.Florida Hospital is recognized byU.S. News & World Report asone of America’s Best Hospitals in Cancer Treatment.Comprising a distinguished body of expert doctors, nurses and researchers, our highly effective treatments are offered through cancer treatment hubs state-wide, with the Comprehensive Cancer Center in Volusia, Cancer Institute in Orlando and Celebration, and the Don Lau Family Center for Cancer Care in Tampa.

Our nationally-recognized services achieve outcomes that typically exceed industry standards and include Central Floridas most robust programs in research and clinical trials.

Florida Hospital is one of the premier cancer research and treatment facilities in the nation. From our nationally recognized clinical research center to our one-on-one support that treats the whole person mind, body and spirit we offer patients expert services and state-of-the-art technologies in a caring, community hospital setting.

Florida HospitalCancer Instituteis accredited as a Comprehensive Cancer Center by the American College of Surgeons Commission on Cancer. We maintain research affiliations with some of the leading cancer research centers in the world, including UCLAs prestigious Jonsson Comprehensive Cancer Center and the Sarah Cannon Research Institute.

At the heart of our cancer program is our sincere commitment to making a difference in the life of each patient we serve. We guide patients through every step of their treatment plan with comprehensive educational, emotional and spiritual support. We believe this is so important to the healing process that we offer a dedicated team of Cancer Care Coordinators to help you navigate your journey toward wellness. These compassionate health care providers deliver care in a logical, connected and timely manner, so that both your medical and personal needs are met.

Florida Hospital is one of the most active clinical trial sites in the state. Through ongoing nationally recognized cancer research and trials, we are able to offer treatments that wont be available to the general public for months, even years, from now. These clinical trials are conducted by our expert team of surgeons, physicians, specialists and nurses who are dedicated to improving the detection, treatment and outcome of cancer-related diseases. We are proud of our role in finding new ways to treat and beat cancer on all fronts.

Read this article:
Cancer (Oncology) | Florida Hospital

Posted in Oncologist | Comments Off

5th International Conference and Exhibition on Cell and …

Track-1 Cell Therapy:

Cell therapyas performed by alternativemedicinepractitioners is very different from the controlled research done by conventionalstem cellmedical researchers. Alternative practitioners refer to their form of cell therapy by several other different names includingxenotransplanttherapy,glandular therapy, and fresh cell therapy. Proponents ofcell therapyclaim that it has been used successfully to rebuild damaged cartilage in joints, repair spinal cord injuries,strengthen a weakenedimmune system, treat autoimmune diseases such as AIDS, and help patients withneurological disorderssuch as Alzheimers disease,Parkinson’s diseaseand epilepsy.

Related Conferences:

6th International Conference onTissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; 8th World Congress and Expo onCell & Stem Cell Research,Orlando, USA, March 20-22, 2017; 15thWorld Congress on Biotechnology and Biotech Industries Meet,Rome, Italy,March 20-21,2017; 2nd International Conference onGenetic Counselling and Genomic Medicine ,Beijing, China,July 10-12, 2017; International Conference onClinical and Molecular Genetics, Las Vegas, USA, April 24-26, 2017.

Track-2 Gene therapy:

Gene therapyand cell therapy are overlapping fields of biomedical research with the goals of repairing the direct cause of genetic diseases in the DNA orcellularpopulation, respectively. The development of suitablegene therapytreatments for manygenetic diseasesand some acquired diseases has encountered many challenges and uncovered new insights into gene interactions and regulation. Further development often involves uncovering basic scientific knowledge of the affected tissues, cells, and genes, as well as redesigning vectors, formulations, and regulatory cassettes for the genes.Cell therapyis expanding its repertoire of cell types for administration.Cell therapytreatment strategies include isolation and transfer of specific stem cell populations, administration of effector cells, and induction of mature cells to becomepluripotent cells, and reprogramming of mature cells.

Related Conferences:

2nd International Conference onMolecular Biology , London, UK ,June 22-24, 2017; 3rd World Bio Summit & Expo, Abu Dhabi, UAE, June 19-21, 2017; 5th International Conference onIntegrative Biology, London, UK, June 19-21, 2017; 2nd World Congress on Human Genetics, Chicago, USA, July 24-26, 2017; 9th International Conference onGenomics and Pharmacogenomics, Chicago, USA, July 13-14, 2017.

ConferenceSeries LLC welcomes you to attend the6thInternational Conference and Exhibition on Cell & Gene Therapyduring March 2-3, 2017 at Madrid,Spain. We cordially invite all the participants who are interested in sharing their knowledge and research in the arena ofCell & Gene Therapy.

Cell and Gene Therapy Conferenceis to ameliorate the knowledge, awareness, and education on cell and gene therapy leading to the discovery of genetic and cellular therapies which aid to alleviate the human disease as it is the most significant emerging technology in the eyes of Medical, Biotechnology, Pharmaceuticals and Academia.Cell and Gene Therapy Conference 2017 is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists.

Cell Therapy Conferenceswill provide a perfect platform to all the Doctors, Researchers Business Delegates and Scientists to approach and deliver all the attendees about the latest scientific advancements on the respective sphere.

Gene Therapy Conferencesstrategic astuteness is to be an event for bringing together Scientists, Physicians, International mix of leading Universities,Cell Gene TherapyInstitutions to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.

This two-dayGene Therapy Eventwill address key issues concerning cell and gene therapy in the broader context of cellular and genetic disorder. Organized around daily themes, the Conference focuses on moving from present knowledge to future solutions

Global markets for stem cells by BCC Research (2012), cited by Ministry of Food and Drug Safety, predicted the global market size of stem cell therapy product would be 6.6 billion dollars in 2016 and grow 11.7% on average every year. Currently, Europe cell therapy and gene therapy occupy share market of 872 million dollars. Europe’s is 10.9% (1.5 billion dollars in 2016).

OMICS International Organises 300+International ConferencesEvery Year across Europe,USA & Asia with support from 1000 morescientificsocietiesand Publishes 400+Open access journalswhich contains over 30000 eminent personalities, reputed scientists as editorial board members.

The previous conferences on Cell & Gene Therapy which were held at San Antonio, USAandLondon, UKhave explained Research & Advancements in Cell and Gene Therapy, gained so much of interest for eminent scientists all over the world in the field of Cell & Gene Therapy. Now it is the time for the 6thInternational Conference and Exhibition on Cell & Gene Therapyto addressExploring the novel research and innovations in Cell and Gene therapy which will be held on March 2-3,2017 at Madrid, Spain.

Target Audience

Cell and Gene Therapy Students, Scientists

Cell and Gene Therapy Researchers

Cell and Gene Therapy Faculty

Cell and Gene Therapy Associations and Societies

Cell and Gene Therapy physicians

Cell and Gene Therapy advanced practice registered nurses,

Allied health professionals in the fields of Cell and Gene Therapy,hematology, oncology, neurology, family medicine and internal medicine.

Stem Cell Students, Scientists

Stem Cell Researchers

Stem Cell Faculty

Stem Cell Associations and Societies

Business Entrepreneurs

Training Institutes

Software developing companies

OMICS International Conferencessuccessfully hosted its premier5th International Conference and Exhibition on Cell and Gene Therapy during May19-21, 2016 at Hilton San Antonio Airport, San Antonio, USA

The conference brought together a comprehensive range of the cell and gene therapy researchers, educators from research universities as well as representatives from industry and professional cell and gene therapy societies.

Cell Therapy-2016 is known for uplifting the future of cell and gene therapy and its allied areas by encouraging students and fellow researchers to present their work through poster presentations and young research forum. Students participated with great zeal and the best posters were awarded for their efforts and outstanding contribution to the cell and gene therapy research.

OMICS InternationalConferences wishes to acknowledge with its deep sincere gratitude to all the supporters from the Editorial Board Members of our Open Access Journals, Keynote speakers, Honourable guests, valuable speakers, poster presenters, students, delegates and special thanks to the media partners, Exhibitorsfor their promotion to make this event a huge success.

This5th International Conference and Exhibition on Cell and Gene Therapy based on the themeFrontiers in Cell and Gene Therapy: From Bench to Bedsidewhich covered the below scientific sessions like Gene Therapy, Cell and Gene Therapy Products, Cellular Therapy, Cancer Gene Therapy, Nano Therapy, Skin Cell Therapy, HIV Gene Therapy, Diabetes for Gene Therapy, Viral Gene Therapy, Stem Cell Therapies, Stem Cell Preservation, Stem Cell Products, Genetically Inherited diseases, Plant Stem Cells, Plant Stem Cell Rejuvenation, Clinical Trials in Cell & Gene Therapy, Molecular Epigenetics, Bioengineering Therapeutics, Advanced Gene Therapeutics, Ethical Issues of Therapies,.

The conference was greeted by the conference Moderator:Dr. Juliann G. Kiang, Uniformed Services University of The Health Sciences, USA. The support was extended by the Keynote Speaker: Dr. Vikas Kundra, MD Anderson Cancer Centre, USA; Dr. Jennifer Grinnell, Biosheprix, USA; Dr. Heidi Strona, PeproTech, USA

OMICSInternationalacknowledges the support of below Chairs and Co-chairs with whom we were able to run the scientific sessions smoothly it included: Dr. Chan-Wha Kim, Korea University College of Life Sciences and biotechnology, Korea; Dr. Juliann G Kiang, Uniformed Services University of The Health Sciences, USA; Dr. Michail Ponizovskiy, Kiev regional p/n hospital, Germany.

This 5th International Conference and Exhibition on Cell and Gene Therapy was uplifted with more than 32 oral presentations by researchers, scientists, professors, industry delegates and more than 15 poster participants around the globe. OMICS International has taken the privilege of felicitating Cell Therapy-2016 Organizing Committee Members, Editorial Board Members of the supported Journals and Keynote Speakers who supported for the success of this event

Follow this link:
5th International Conference and Exhibition on Cell and …

Posted in Stem Cell Cancer | Comments Off

Bay Regional Cancer Center, Panama City, Florida

We understand that receiving a diagnosis of cancer can be frightening and confusing. To help you and your family better understand the treatment options available to you, we have created this web site to explain how radiation therapy is used to safely and effectively treat cancer.

Bay Regional Cancer Centeris dedicated to the treatment of all types of cancer. Our mission is to provide the most effective and provencancer treatmentto our patients in a respectful and compassionate manner . We are the only cancer center in the area with Smart Adapt, Smart Segmentation, IMRT (Intensity modulated radiation treatment), Rapid Arc (see link below), IGRT (image guided radiation treatment) and both high and low energy photon beams.

We are proud to provide world class advanced cancer care customized for each patient in a community setting close to friends, family and home.

Our services include:

We invite you to contact us today at (850) 747-6972 to schedule an appointment.

This material is informational only and should not be used in place of advice from a medical professional. If you have questions about a specific treatment, please call (850) 747-6972.

Link:
Bay Regional Cancer Center, Panama City, Florida

Posted in Oncology | Comments Off